Research programme: antivirals - Pfizer
Alternative Names: Antivirals research programme - Pfizer; Research programme: tricyclic non-nucleoside inhibitors - Pfizer; Tricyclic non-nucleoside inhibitors research programme - PfizerLatest Information Update: 30 Dec 2021
At a glance
- Originator Pfizer
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cytomegalovirus infections; Herpes simplex virus infections
Most Recent Events
- 03 Oct 2000 Preclinical development for Cytomegalovirus infections in USA (Unknown route)
- 03 Oct 2000 Preclinical development for Herpes simplex virus infections in USA (Unknown route)